Causes of Elevated D-Dimer
Elevated D-dimer reflects both coagulation activation (fibrin clot formation) and fibrinolysis (clot breakdown), occurring in any condition that generates and degrades cross-linked fibrin. 1
Primary Pathophysiologic Mechanism
D-dimer is generated specifically from plasmin-mediated proteolysis of cross-linked fibrin, making it a marker of both thrombosis and fibrinolytic activity. 1 The presence of D-dimer indicates that fibrin clots have formed and are being broken down, with a plasma half-life of approximately 16 hours. 1
Major Clinical Causes
Thrombotic Conditions
- Venous thromboembolism (VTE): Deep vein thrombosis and pulmonary embolism are the most common diagnoses when D-dimer exceeds 5000 ng/mL, with median levels of 3.36 g/L and 3.07 g/L respectively. 2
- Aortic pathology: Aortic aneurysm demonstrates the highest median D-dimer levels at 5.46 g/L, with aortic dissection also showing significantly elevated levels. 2
Infectious and Inflammatory Conditions
- Respiratory infections: Found in 9.2% of patients with elevated D-dimer, with median levels of 0.76 g/L. 2
- Sepsis: Associated with markedly elevated D-dimer as part of systemic inflammatory response. 1
- COVID-19: Elevated D-dimers detected in infected patients, associated with disease severity and mortality in multiple studies. 1
Acute Medical Conditions
- Disseminated intravascular coagulation (DIC): Causes several-fold increases in D-dimer levels. 1
- Acute respiratory distress syndrome (ARDS): Associated with significantly elevated D-dimer. 1
- Acute myocardial infarction: Produces elevated D-dimer through thrombotic and inflammatory mechanisms. 1
- Trauma and surgery: Both cause substantial D-dimer elevation (14.1% of cases with markedly elevated levels). 3
Malignancy
- Active cancer: Accounts for 10.6% of patients with very high D-dimer levels, including both newly diagnosed and active known cancers. 3
- Cancer patients with markedly elevated D-dimer show significantly poorer survival outcomes compared to those without cancer. 3
Cardiovascular Disease
- Heart failure: Significantly associated with elevated D-dimer in emergency department populations. 4
- Stroke: Associated with D-dimer elevation. 4
Physiologic Conditions
- Advanced age: D-dimer levels increase with aging, leading to the validated age-adjusted cutoff (age × 10 µg/L for patients ≥50 years). 5
- Pregnancy: Physiologically elevated D-dimer occurs during normal pregnancy. 6
- Strenuous physical activity: Can transiently elevate D-dimer levels. 6
Other Conditions
- Anemia: Significantly associated with elevated D-dimer in unselected emergency department patients. 4
- Diabetes: Associated with higher D-dimer levels. 1
- Bleeding disorders: Can elevate D-dimer through fibrinolytic activation. 7
Clinical Context and Prognostic Significance
Patients with D-dimer levels >15,000 ng/mL have 75% mortality when no clear diagnosis is identified, compared to 24% mortality in the 5000-10,000 ng/mL range. 7 This underscores that ultra-high D-dimer levels indicate severe underlying disease regardless of specific etiology.
In unselected emergency department populations, 47% of patients have elevated D-dimer (≥0.5 mg/L), and these patients demonstrate higher rates of hospital admission, healthcare re-presentation, and 90-day mortality (8.1%) compared to 1.2% mortality in those with normal D-dimer. 4
Important Caveats
- Multiple concurrent diagnoses: 61% of patients with markedly elevated D-dimer have multiple contributing conditions, making single-cause attribution problematic. 7
- No identifiable cause: In 11.3% of patients with ultra-high D-dimer levels, no clear etiology can be identified despite thorough evaluation. 7
- Assay variability: D-dimer testing lacks standardization, with significant variability in sensitivity, specificity, and reporting units across different commercial assays. 1, 8